1. The malignant hyperthermia syndrome;Nelson, T.E.; Flewellen, E.H.;N Engl J Med,1983
2. Immunological associations of acquired neuromyotonia;Newsom-Davis, J.; Mills, K.R.;Brain,1993
3. The effect of calcium channel antagonists;Foster, P.S.; Denborough, M.A.;Int J Biochem; 8644 on calcium fluxes of malignant hyperthermia susceptible muscle,1993
4. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease;Smith, C.A.D.; Cough, A.C.; Leigh, P.N.; Summers, B.A.; Harding, A.E.; Maraganore, D.M.;Lancet,1992
5. Mutant debrisoquine hydroxylation genes in Parkinson's disease;Armstrong, M.; Daly, A.K.; Cholerton, S.; Bateman, D.N.; Idle, JR;Lancet,1992